Marshall Wace North America’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-51,833
| Closed | -$3.22M | – | 1452 |
|
|
2019
Q3 | $3.22M | Sell |
51,833
-18,167
| -26% | -$1.13M | 0.02% | 444 |
|
|
2019
Q2 | $4.99M | Sell |
70,000
-43,901
| -39% | -$3.13M | 0.03% | 363 |
|
|
2019
Q1 | $8.93M | Buy |
113,901
+95,539
| +520% | +$7.49M | 0.06% | 222 |
|
|
2018
Q4 | $1.56M | Buy |
+18,362
| New | +$1.56M | 0.02% | 495 |
|
|
2017
Q4 | – | Sell |
-3,498
| Closed | -$297K | – | 1502 |
|
|
2017
Q3 | $297K | Buy |
+3,498
| New | +$297K | ﹤0.01% | 1135 |
|
|
2013
Q4 | $2.14M | Buy |
65,253
+59,873
| +1,113% | +$1.96M | 0.05% | 285 |
|
|
2013
Q3 | $145K | Buy |
+5,380
| New | +$145K | ﹤0.01% | 572 |
|